Triangle cell therapy startup Inceptor Bio closes $37M in Series A funding
Cell and gene therapy startup Inceptor Bio, which raised $26 million in seed capital not long ago, has added more than $37 million in Series A funding.
Read MorePosted by Jason Parker | May 19, 2022
Cell and gene therapy startup Inceptor Bio, which raised $26 million in seed capital not long ago, has added more than $37 million in Series A funding.
Read MorePosted by WRAL TechWire | Dec 21, 2021
RALEIGH – Kineticos Life Sciences, which launched in 2020 with a fund topping $5 million, is rolling out a second fund and has already pulled in $55 million, according to an SEC filing. Kineticos wants to raise $100 million and has already secured 17 backers, the filing notes. To date,...
Read MorePosted by WRAL News | Sep 30, 2020
The Raleigh-based firm identifies, incubates and accelerates novel technologies to advance progress for curing cancer and neurodegenerative diseases.
Read More